Drug intelligence / Profile preview

Aceboat Cold

Development stage
Unknown
Lead developer
Zeebharat Med Private Limited
Modality
Small Molecules
Administration
Oral
01

Overview

Aceboat Cold is a fixed-dose combination medication developed by Zeebharat Med Private Limited, primarily indicated for the symptomatic relief of the common cold, fever, and associated allergic symptoms. The formulation combines four active ingredients: aceclofenac, a non-steroidal anti-inflammatory drug (NSAID) that primarily inhibits cyclooxygenase-2 (COX-2) to reduce pain and inflammation; paracetamol (acetaminophen), an analgesic and antipyretic that provides relief from fever and mild-to-moderate pain; phenylephrine hydrochloride, a sympathomimetic decongestant that acts as an alpha-1 adrenergic receptor agonist to reduce nasal congestion; and cetirizine, a second-generation H1-antihistamine that blocks histamine receptors to alleviate allergic symptoms such as sneezing and rhinorrhea. This multi-modal approach addresses the complex symptoms of upper respiratory tract infections and allergic rhinitis.

Brand names
Aceboat Cold
Other names
Aceclofenac + Paracetamol + Phenylephrine HCl + Cetirizine
02

Targets

PTGS2 (Prostaglandin-Endoperoxide Synthase 2)ADRA1A (α1A)PGHS-1 (Prostaglandin G/H Synthase 1)HRH1 (Histamine H1 Receptor)

Beyond the preview

Go deeper on Aceboat Cold.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Aceboat Cold.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call